CD4 and colorectal carcinoma: We previously showed that vaccination with RNA-LPX encoding for CD4+T cell neoantigens augments cellular responses generated by LRT via in situ release of tumor antigens in a mouse tumor model of colorectal carcinoma, CT26 [25].